Postantibiotic Effect of Ceftaroline against Gram-Positive Organisms

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects (SMEs) of ceftaroline, a novel injectable cephalosporin, were determined for 15 gram-positive organisms. The pneumococcal, staphylococcal, and enterococcal PAEs were 0.8 to 1.8 h, 0.7 to 2.2 h, and 0.2 to 1.1 h, respectively. The corresponding PA-SMEs (0.4 times the MIC) were 2.5 to 6.7 h, 2.9 to >0.0 h, and 7.9 to >10.3 h, respectively. The PA-SMEs were longer than the PAEs, suggesting that sub-MIC levels extend the PAE of ceftaroline against gram-positive cocci.

Knowledge Graph

Similar Paper

Postantibiotic Effect of Ceftaroline against Gram-Positive Organisms
Antimicrobial Agents and Chemotherapy 2009.0
Postantibiotic Effect of Tigecycline against 14 Gram-Positive Organisms
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria
Antimicrobial Agents and Chemotherapy 2010.0
Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2008.0
Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
Antimicrobial Agents and Chemotherapy 2010.0
In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2009.0